INDIA Cases - 216,824, Deaths - 6,088
Global Cases - 6,567,393, Deaths - 387,913
The Maharashtra government has approached the Indian Council of Medical Research (ICMR) and the Drug Controller General (DCG) with an application seeking permission to use the BCG vaccine for clinical trials on COVID-19 patients. Researchers at the Haffkine Institute in Mumbai are constantly working on it, Early research has also revealed that people who have been using the BCG vaccine, their body immunity is much better in fighting coronavirus. Maharashtra government asked for permission for clinical tests. Scientists from all over the world are trying to prepare vaccines to protect against the coronavirus, but so far no one has been successful. Fast work is being done in this direction in India too. Meanwhile, good news has come from Mumbai. Research is being done on a 90-year-old medicine here and its results in corona fight are still being reported as good.
Research is being done on this medicine at the Haffkine Institute in Parel, Mumbai. This vaccine is BCG ie Bacillus Calmette-Guerin. It took 13 years between 1908 and 1921 to make this vaccine. It was created by the French bacteriologist Albert Kalmet and Camil Gurin. Till now BCG is used for TB patients. But if the results are better, then this vaccine can become a big weapon against COVID 19 too.
Early research has also revealed that people who have been using the BCG vaccine, their body immunity is much better in fighting coronavirus. On this basis, the researchers believe that only those who have consumed this vaccine due to the disease are stronger in defeating the corona. That is why the researchers believe that if the vaccine is given to the people, then not only the symptoms of corona are expected to decrease but its effect may also be reduced. If someone has severe symptoms of the corona, then this vaccine can also cause deterioration and the patient's condition can improve.
Dr. Sanjay Mukherjee of the Department of Medical Education and Drugs told the new portal that Haffkine Institute has done a preliminary study and its results have come out positive. Based on this, such institutes have been identified where further research can be done on this vaccine. While preparations are being made to intensify further research on the vaccine, the Haffkine Institute is planning to use the BCG vaccine on those who are corona infected.
Must Read: Coronavirus India Update Lockdown Day 21
A letter has also been written in this regard to the ICMR and the Drug Controller of India. Ajay Mehta, Chief Secretary, Government of Maharashtra, has sought permission to proceed with the BCG vaccine so that it can be used in clinical trials.